Zipp F - Search Results

1

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. Aktas O, et al. Among authors: zipp f. J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.

2

Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells--implications for multiple sclerosis.

Wendling U, Aktas O, Schmierer K, Zschenderlein R, Zipp F. Wendling U, et al. Among authors: zipp f. J Neuroimmunol. 2000 Feb 1;103(1):69-75. doi: 10.1016/s0165-5728(99)00214-3. J Neuroimmunol. 2000. PMID: 10674991

3

Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.

Wendling U, Walczak H, Dörr J, Jaboci C, Weller M, Krammer PH, Zipp F. Wendling U, et al. Among authors: zipp f. Cell Death Differ. 2000 Jul;7(7):637-44. doi: 10.1038/sj.cdd.4400692. Cell Death Differ. 2000. PMID: 10889508

4

Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells.

Zipp F, Wendling U, Beyer M, Grieger U, Waiczies S, Wagenknecht B, Haas J, Weller M. Zipp F, et al. J Neuroimmunol. 2000 Oct 2;110(1-2):214-22. doi: 10.1016/s0165-5728(00)00337-4. J Neuroimmunol. 2000. PMID: 11024552

5

[Apoptosis in multiple sclerosis. Etiopathogenetic relevance and prospects for new therapeutic strategies].

Aktas O, Wendling U, Zschenderlein R, Zipp F. Aktas O, et al. Among authors: zipp f. Nervenarzt. 2000 Oct;71(10):767-73. doi: 10.1007/s001150050664. Nervenarzt. 2000. PMID: 11082807 Review. German.

6

Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis.

Aktas O, Waiczies S, Grieger U, Wendling U, Zschenderlein R, Zipp F. Aktas O, et al. Among authors: zipp f. J Neuroimmunol. 2001 Mar 1;114(1-2):160-7. doi: 10.1016/s0165-5728(01)00243-0. J Neuroimmunol. 2001. PMID: 11240027

7

Downregulation of transforming growth factor-beta1 in interferon-beta1a-treated MS patients.

Lünemann JD, Aktas O, Gniadek P, Zschenderlein R, Zipp F. Lünemann JD, et al. Among authors: zipp f. Neurology. 2001 Sep 25;57(6):1132-4. doi: 10.1212/wnl.57.6.1132. Neurology. 2001. PMID: 11571354

8

Induction of TRAIL-mediated glioma cell death by human T cells.

Dörr J, Waiczies S, Wendling U, Seeger B, Zipp F. Dörr J, et al. Among authors: zipp f. J Neuroimmunol. 2002 Jan;122(1-2):117-24. doi: 10.1016/s0165-5728(01)00450-7. J Neuroimmunol. 2002. PMID: 11777550

9

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.

Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F. Dörr J, et al. Among authors: zipp f. J Neurosci. 2002 Feb 15;22(4):RC209. doi: 10.1523/JNEUROSCI.22-04-j0001.2002. J Neurosci. 2002. PMID: 11844843 Free PMC article.

10

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells.

Lünemann JD, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T, Zipp F. Lünemann JD, et al. Among authors: zipp f. J Immunol. 2002 May 15;168(10):4881-8. doi: 10.4049/jimmunol.168.10.4881. J Immunol. 2002. PMID: 11994437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters